How can you ensure your IRT strategy is meeting the demands of our changing trial landscape? This industry report reveals qualitative and quantitative candid insight from clinical development insiders and their views on current clinical …
How can you ensure your IRT strategy is meeting the demands of our changing trial landscape? This industry report reveals qualitative and quantitative candid insight from clinical development insiders and their views on current clinical …
Intelligent Trials Success Stories is a collection of 5 case studies, ranging from top 10 sponsors to mid-sized CROs, that gives a behind-the-scenes look at how biopharmaceutical organizations are using AI-enabled technology and advanced analytics to o…
Intelligent Trials Success Stories is a collection of 5 case studies, ranging from top 10 sponsors to mid-sized CROs, that gives a behind-the-scenes look at how biopharmaceutical organizations are using AI-enabled technology and advanced analytics to o…
Billions of dollars of revenue and tens of billions of dollars of market valuation have been erased in pharma over the last year due to COVID-related market conditions. These are funds that could have been used to reinvest in clinical development, dise…
Billions of dollars of revenue and tens of billions of dollars of market valuation have been erased in pharma over the last year due to COVID-related market conditions. These are funds that could have been used to reinvest in clinical development, dise…
Vaccines are one of the most effective weapons we have in the battle against deadly and crippling diseases. Efficiently developing, testing, and producing vaccines can help save lives. This is more relevant than ever as we fight COVID-19 and look for w…
Vaccines are one of the most effective weapons we have in the battle against deadly and crippling diseases. Efficiently developing, testing, and producing vaccines can help save lives. This is more relevant than ever as we fight COVID-19 and look for w…
The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022. It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizat…
The seasonal influenza vaccine market is projected to reach more than $4 Billion USD by the end of 2022. It is a safe assumption that as demand for seasonal influenza vaccines increases, so too with the demand for contract manufacturing organizat…
